It is unclear whether higher thresholds of non-high-density lipoprotein cholesterol are more strongly associated with metabolic syndrome in adolescents and young adults with obesity. Therefore, authors of a...
Authors of a new study presented at the AHA Scientific Sessions 2019 sought to determine whether cardiac biomarkers could identify patients at higher baseline risk for cardiovascular mortality or heart...
The authors of a new study sought to determine whether a risk calculator could accurately determine the 7-year morbidity and mortality rates among patients with type 2 diabetes and obesity who may be...
In a new study, researchers examined the association between treatment with metformin vs sulfonylureas and major adverse cardiovascular events among 49,478 US veterans with diabetes and reduced kidney...
The number of individuals with both diabetes and heart failure is expected to increase. To outline management approaches and the need for future research in treating the conditions, the American Heart...
In response to results from a placebo-controlled trial on the use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes and chronic kidney disease, the ADA has released new updates to their...
Researchers determined whether a high-intensity or moderate-intensity exercise program would be more beneficial for patients with metabolic syndrome in cardiac rehabilitation. The findings will be presented...
Through a systematic review of past studies, researchers are determining the effect of improving diet, behavior, and/or physical can have on obesity prevention policies.
